However, the fact that ATP13A2 appears in this work as a new TFEB regulator provides a hypothetical and indirect pathophysiological context for the plausible contribution of TFEB to the development of PD and, eventually, other neurodegenerative disorders. The gene discussed is TFEB; the disease is Parkinson disease.